|
|
|
Insider
Information: |
Hutson Nancy J |
Relationship: |
Director |
City: |
Durham |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
217,328 |
|
Indirect Shares
|
5,000 |
|
|
Direct
Value |
$669,778 |
|
|
Indirect Value
|
$1 |
|
|
Total
Shares |
222,328 |
|
|
Total
Value |
$669,779 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
7
|
1
|
Stock
price went up :
|
4
|
0
|
Stock
price went down : |
3
|
1
|
|
|
|
Gain/Loss Ratio : |
1.3
|
-1.0
|
Percentage
Gain/Loss : |
6.6%
|
-30.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Endo Health Solutions Inc |
ENDP |
Director |
2014-02-28 |
0 |
2010-12-07 |
1,000 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2024-05-20 |
86,818 |
|
0 |
Premium* |
|
Phasebio Pharmaceuticals Inc |
PHAS |
Director |
2023-05-19 |
37,510 |
2023-05-19 |
4,000 |
Premium* |
|
Clearside Biomedical, Inc. |
CLSD |
Director |
2023-10-03 |
93,000 |
2020-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2018-06-01 |
4 |
A |
$6.43 |
$9,999 |
D/D |
1,555 |
39,702 |
0 |
- |
|
PHAS |
Phasebio Pharmaceuticals ... |
Director |
|
2018-12-17 |
4 |
B |
$4.46 |
$4,460 |
I/I |
1,000 |
1,000 |
2.1 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-09-01 |
4 |
A |
$2.99 |
$9,999 |
D/D |
3,344 |
43,046 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-11-18 |
4 |
B |
$1.45 |
$14,500 |
D/D |
10,000 |
53,046 |
2.39 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2019-12-01 |
4 |
A |
$2.85 |
$9,998 |
D/D |
3,508 |
56,554 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-03-01 |
4 |
A |
$3.00 |
$9,999 |
D/D |
3,333 |
59,887 |
0 |
- |
|
CLSD |
Clearside Biomedical, Inc... |
Director |
|
2020-05-20 |
4 |
B |
$1.85 |
$9,250 |
D/D |
5,000 |
5,000 |
2.39 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-06-01 |
4 |
A |
$4.50 |
$9,997 |
D/D |
2,224 |
62,111 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-08-31 |
4 |
A |
$4.15 |
$4,997 |
D/D |
1,204 |
63,315 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2020-11-30 |
4 |
A |
$5.11 |
$4,998 |
D/D |
978 |
64,293 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-02-26 |
4 |
A |
$10.78 |
$4,991 |
D/D |
463 |
64,756 |
0 |
- |
|
CLSD |
Clearside Biomedical, Inc... |
Director |
|
2021-03-12 |
4 |
B |
$3.11 |
$15,525 |
D/D |
5,000 |
10,000 |
2.39 |
% |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-05-28 |
4 |
A |
$15.77 |
$4,999 |
D/D |
317 |
65,073 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-06-10 |
4 |
OE |
$2.85 |
$73,549 |
D/D |
23,333 |
88,406 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-06-10 |
4 |
AS |
$16.86 |
$393,394 |
D/D |
(23,333) |
65,073 |
0 |
% |
|
CLSD |
Clearside Biomedical, Inc... |
Director |
|
2021-08-16 |
4 |
B |
$5.68 |
$17,040 |
D/D |
3,000 |
13,000 |
2.39 |
% |
|
PHAS |
Phasebio Pharmaceuticals ... |
Director |
|
2021-08-18 |
4 |
B |
$3.08 |
$9,240 |
I/I |
3,000 |
4,000 |
2.1 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-10-15 |
4 |
OE |
$1.71 |
$363,450 |
D/D |
105,000 |
170,073 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2021-10-15 |
4 |
AS |
$15.40 |
$1,617,000 |
D/D |
(105,000) |
65,073 |
0 |
% |
|
CLSD |
Clearside Biomedical, Inc... |
Director |
|
2021-10-29 |
4 |
OE |
$2.00 |
$81,350 |
D/D |
40,000 |
53,000 |
0 |
- |
|
PHAS |
Phasebio Pharmaceuticals ... |
Director |
|
2021-11-05 |
4 |
OE |
$2.26 |
$60,909 |
D/D |
26,360 |
26,360 |
0 |
- |
|
PHAS |
Phasebio Pharmaceuticals ... |
Director |
|
2021-11-08 |
4 |
OE |
$3.15 |
$23,310 |
D/D |
7,400 |
33,760 |
0 |
- |
|
CLSD |
Clearside Biomedical, Inc... |
Director |
|
2022-11-17 |
4 |
B |
$1.33 |
$39,900 |
D/D |
30,000 |
83,000 |
2.39 |
% |
|
PHAS |
Phasebio Pharmaceuticals ... |
Director |
|
2023-05-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
37,510 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Director |
|
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
16,745 |
94,684 |
0 |
- |
|
53 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|